Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

SARS-CoV-2, the virus responsible for COVID-19 ... However, mutations in the spike protein can alter its structure, reducing ...

Identification of HKU5-CoV-2 (a member of the HKU5 lineage 2), a new merbecovirus found in bats of Zhejiang, Anhui, and ...

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Cryo-EM structure of the spike complexed ... enhances the antibody-mediated neutralisation of SARS-CoV-2 via increased inhibition of virus-host interactions. Here the authors characterise the ...

The SARS-CoV-2 virus has been observed to infect human neurons ... where the virus is first taken up into an intracellular structure known as an endosome. In the endosome, enzymes such as cathepsins ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...